O'Day SJ - Search Results

1

BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma.

Kim KB, Sosman JA, Fruehauf JP, Linette GP, Markovic SN, McDermott DF, Weber JS, Nguyen H, Cheverton P, Chen D, Peterson AC, Carson WE 3rd, O'Day SJ. Kim KB, et al. J Clin Oncol. 2012 Jan 1;30(1):34-41. doi: 10.1200/JCO.2011.34.6270. Epub 2011 Nov 28. J Clin Oncol. 2012. PMID: 22124101 Free PMC article. Clinical Trial.

2

Advantages of concurrent biochemotherapy modified by decrescendo interleukin-2, granulocyte colony-stimulating factor, and tamoxifen for patients with metastatic melanoma.

O'Day SJ, Gammon G, Boasberg PD, Martin MA, Kristedja TS, Guo M, Stern S, Edwards S, Fournier P, Weisberg M, Cannon M, Fawzy NW, Johnson TD, Essner R, Foshag LJ, Morton DL. O'Day SJ, et al. J Clin Oncol. 1999 Sep;17(9):2752-61. doi: 10.1200/JCO.1999.17.9.2752. J Clin Oncol. 1999. PMID: 10561350

3

Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma.

Agarwala SS, Glaspy J, O'Day SJ, Mitchell M, Gutheil J, Whitman E, Gonzalez R, Hersh E, Feun L, Belt R, Meyskens F, Hellstrand K, Wood D, Kirkwood JM, Gehlsen KR, Naredi P. Agarwala SS, et al. J Clin Oncol. 2002 Jan 1;20(1):125-33. doi: 10.1200/JCO.2002.20.1.125. J Clin Oncol. 2002. PMID: 11773161 Clinical Trial.

4

Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapy.

O'Day SJ, Boasberg PD, Piro L, Kristedja TS, Wang HJ, Martin M, Deck R, Ames P, Shinn K, Kim H, Fournier P, Gammon G. O'Day SJ, et al. Clin Cancer Res. 2002 Sep;8(9):2775-81. Clin Cancer Res. 2002. PMID: 12231516 Clinical Trial.

5

Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine.

Hsueh EC, Essner R, Foshag LJ, Ollila DW, Gammon G, O'Day SJ, Boasberg PD, Stern SL, Ye X, Morton DL. Hsueh EC, et al. J Clin Oncol. 2002 Dec 1;20(23):4549-54. doi: 10.1200/JCO.2002.01.151. J Clin Oncol. 2002. PMID: 12454111 Clinical Trial.

6

Biochemotherapy for metastatic melanoma with limited central nervous system involvement.

Boasberg PD, O'Day SJ, Kristedja TS, Martin M, Wang H, Deck R, Shinn K, Ames P, Tamar B, Petrovich Z. Boasberg PD, et al. Oncology. 2003;64(4):328-35. doi: 10.1159/000070289. Oncology. 2003. PMID: 12759528 Clinical Trial.

7

Impact of gene polymorphisms on clinical outcome for stage IV melanoma patients treated with biochemotherapy: an exploratory study.

Liu D, O'Day SJ, Yang D, Boasberg P, Milford R, Kristedja T, Groshen S, Weber J. Liu D, et al. Clin Cancer Res. 2005 Feb 1;11(3):1237-46. Clin Cancer Res. 2005. PMID: 15709194

8

Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.

Koyanagi K, O'Day SJ, Gonzalez R, Lewis K, Robinson WA, Amatruda TT, Wang HJ, Elashoff RM, Takeuchi H, Umetani N, Hoon DS. Koyanagi K, et al. J Clin Oncol. 2005 Nov 1;23(31):8057-64. doi: 10.1200/JCO.2005.02.0958. J Clin Oncol. 2005. PMID: 16258104 Free PMC article.

9

Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.

Mori T, O'Day SJ, Umetani N, Martinez SR, Kitago M, Koyanagi K, Kuo C, Takeshima TL, Milford R, Wang HJ, Vu VD, Nguyen SL, Hoon DS. Mori T, et al. J Clin Oncol. 2005 Dec 20;23(36):9351-8. doi: 10.1200/JCO.2005.02.9876. J Clin Oncol. 2005. PMID: 16361635 Free PMC article. Clinical Trial.

10

Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.

Lewis KD, Robinson WA, McCarter M, Pearlman N, O'Day SJ, Anderson C, Amatruda TT, Baron A, Zeng C, Becker M, Dollarhide S, Matijevich K, Gonzalez R. Lewis KD, et al. J Clin Oncol. 2006 Jul 1;24(19):3157-63. doi: 10.1200/JCO.2005.04.5344. J Clin Oncol. 2006. PMID: 16809738 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page